Quality of life and mid-term survival of patients bridged with extracorporeal membrane oxygenation to left ventricular assist device

Shinya Unai, Kentaro Yamane, Daizo Tanaka, Gary Cook, Hitoshi Hirose, Nicholas C. Cavarocchi, John W.C. Entwistle

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management, However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown, Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD, Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group), No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group), Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group), Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole, The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38), The postimplant QOL scores of the ECMO-VAD group were not different compared with the primary LVAD group, Although the ECMO-VAD group consists of critically ill patients, the QOL and survival after discharge were not significantly different compared with patients who were not bridged with ECMO,

Original languageEnglish (US)
Pages (from-to)273-278
Number of pages6
JournalASAIO Journal
Volume63
Issue number3
DOIs
StatePublished - Jun 1 2017

Fingerprint

Left ventricular assist devices
Extracorporeal Membrane Oxygenation
Heart-Assist Devices
Oxygenation
Quality of Life
Membranes
Survival
Registries
Quality management
Hospital Mortality
Critical Illness
Heart Failure

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

Unai, Shinya ; Yamane, Kentaro ; Tanaka, Daizo ; Cook, Gary ; Hirose, Hitoshi ; Cavarocchi, Nicholas C. ; Entwistle, John W.C. / Quality of life and mid-term survival of patients bridged with extracorporeal membrane oxygenation to left ventricular assist device. In: ASAIO Journal. 2017 ; Vol. 63, No. 3. pp. 273-278.
@article{2959094ddb154423b232ff6205e0875d,
title = "Quality of life and mid-term survival of patients bridged with extracorporeal membrane oxygenation to left ventricular assist device",
abstract = "Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management, However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown, Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD, Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group), No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group), Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group), Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole, The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23{\%} and 14{\%}, respectively (P = 0.38), The postimplant QOL scores of the ECMO-VAD group were not different compared with the primary LVAD group, Although the ECMO-VAD group consists of critically ill patients, the QOL and survival after discharge were not significantly different compared with patients who were not bridged with ECMO,",
author = "Shinya Unai and Kentaro Yamane and Daizo Tanaka and Gary Cook and Hitoshi Hirose and Cavarocchi, {Nicholas C.} and Entwistle, {John W.C.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1097/MAT.0000000000000471",
language = "English (US)",
volume = "63",
pages = "273--278",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Quality of life and mid-term survival of patients bridged with extracorporeal membrane oxygenation to left ventricular assist device. / Unai, Shinya; Yamane, Kentaro; Tanaka, Daizo; Cook, Gary; Hirose, Hitoshi; Cavarocchi, Nicholas C.; Entwistle, John W.C.

In: ASAIO Journal, Vol. 63, No. 3, 01.06.2017, p. 273-278.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Quality of life and mid-term survival of patients bridged with extracorporeal membrane oxygenation to left ventricular assist device

AU - Unai, Shinya

AU - Yamane, Kentaro

AU - Tanaka, Daizo

AU - Cook, Gary

AU - Hirose, Hitoshi

AU - Cavarocchi, Nicholas C.

AU - Entwistle, John W.C.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management, However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown, Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD, Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group), No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group), Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group), Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole, The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38), The postimplant QOL scores of the ECMO-VAD group were not different compared with the primary LVAD group, Although the ECMO-VAD group consists of critically ill patients, the QOL and survival after discharge were not significantly different compared with patients who were not bridged with ECMO,

AB - Insertion of a left ventricular assist device (LVAD) improves survival and quality of life (QOL) in patients with class IV heart failure failing medical management, However, QOL and survival of patients bridged to LVAD with extracorporeal membrane oxygenation (ECMO) is unknown, Between July 2008 and June 2014, 213 patients underwent insertion of HeartMate II LVAD at two VAD centers without a bridge with a temporary VAD, Extracorporeal membrane oxygenation was used as a bridge before LVAD insertion in 22 Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (ECMO-VAD group), No bridge was used in 21 INTERMACS 1 patients and 170 INTERMACS 2-4 patients (primary LVAD group), Survival was compared between the ECMO-VAD group and INTERMACS 1 patients who underwent a primary LVAD insertion (INTERMACS 1 group), Quality of life was compared between the ECMO-VAD group and the primary LVAD group as a whole, The in-hospital mortality of the ECMO-VAD and INTERMACS1 groups was 23% and 14%, respectively (P = 0.38), The postimplant QOL scores of the ECMO-VAD group were not different compared with the primary LVAD group, Although the ECMO-VAD group consists of critically ill patients, the QOL and survival after discharge were not significantly different compared with patients who were not bridged with ECMO,

UR - http://www.scopus.com/inward/record.url?scp=84995812338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995812338&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000471

DO - 10.1097/MAT.0000000000000471

M3 - Article

C2 - 27861427

AN - SCOPUS:84995812338

VL - 63

SP - 273

EP - 278

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -